RGX-121-3102

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)NCT07236606RGNXPhase 3Active not recruiting2028-04-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.